|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Montana Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MontanaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
SensoPath Technologies, Inc.
| | | Phone: | (406) 587-6338 | Fax: | (406) 587-9670 | Year Established: | 2003 | Main Contact: | Dr. Brenda Spangler, CEO | | Other Contacts: | Charles W. Spangler, CSO Louis Lipinski, President & COO David R. Spangler, CFO
| | Company Description | SensoPath Technologies (SPT) markets proprietary compounds that specifically couple capture agents such as antibodies, antigens, enzymes and peptides to custom designed tethers specifically functionalized for fabrication of self-assembled monolayers on gold, glass, quartz or silicon. SPT's primary focus is preparation of unique and innovative bioactive surfaces for pathogen detection. The company supply in-stock or custom designed and synthesized platforms and surface functionalization materials for applications using a variety of commercial biomedical and analytical instruments. The tethers are particularly well adapted for use with surface plasmon resonance, quartz crystal microbalance, fiber optics and AFM devices, but can be designed for use with many other types of surfaces. | |
|
|
|
|
|